Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Treating adenocarcinoma with bevacizumab

Prof Ken O’Byrne – St James’s Hospital, Dublin, Ireland

Treating adenocarcinoma with bevacizumab ( Prof Ken O’Byrne – St James’s Hospital, Dublin, Ireland )

Myc inhibition in pre-clinical mouse models

Dr Laura Soucek - Vall d'Hebron Institute of Oncology

Myc inhibition in pre-clinical mouse models ( Dr Laura Soucek - Vall d'Hebron Institute of Oncology )

Closing the cancer divide: Implementing the diagonal approach

Dr Felicia Knaul - Harvard Medical School, Boston, USA

Closing the cancer divide: Implementing the diagonal approach ( Dr Felicia Knaul - Harvard Medical School, Boston, USA )

Utility of robotics in the management of CT detected lung nodules

Giulia Veronesi - European Institute of Oncology, Milan, Italy

Utility of robotics in the management of CT detected lung nodules ( Giulia Veronesi - European Institute of Oncology, Milan, Italy )

Inequalities in cancer incidence, mortality and survival

Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK

Inequalities in cancer incidence, mortality and survival ( Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK )

Influence of cachexia on chemotherapy toxicity

Dr Michael Sawyer – University of Alberta, Canada

Influence of cachexia on chemotherapy toxicity ( Dr Michael Sawyer – University of Alberta, Canada )

Patient involvement in improvements in standard of care

Tom Haswell - VNCRI and NCRN Consumer Liaison Groups

Patient involvement in improvements in standard of care ( Tom Haswell - VNCRI and NCRN Consumer Liaison Groups )

Chemotherapy and radiotherapy in advanced local non-small cell lung cancer

Dr Dirk De Ruysscher – University of Leuven, Netherlands

Chemotherapy and radiotherapy in advanced local non-small cell lung cancer ( Dr Dirk De Ruysscher – University of Leuven, Netherlands )

Analysing the efficacy of treatment through Response Evaluation Criteria in...

Dr Yves Menu – Saint Antoine Hospital, Paris, France

Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )

MET inhibitors for non-small cell lung cancer

Prof Georgio Scagliotti – University of Torino, Italy

MET inhibitors for non-small cell lung cancer ( Prof Georgio Scagliotti – University of Torino, Italy )

Treatment of ALK+ lung cancer with crizotinib, Profile 1007

Dr Alice Shaw – Massachusetts General Hospital, Boston, USA

Phase I study examining PI 3 kinase inhibitor for various tumours

Dr Pamela Munster – University of California, San Francisco, USA

Phase I study examining PI 3 kinase inhibitor for various tumours ( Dr Pamela Munster – University of California, San Francisco, USA )

More from ecancer